scholarly article | Q13442814 |
P356 | DOI | 10.1002/HEP.1840380414 |
10.1053/JHEP.2003.50384 | ||
P953 | full work available at URL | http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjhep.2003.50384 |
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.1840380414 | ||
P698 | PubMed publication ID | 14512875 |
P2093 | author name string | Shigeo Mori | |
Yasushi Sugano | |||
Katsunori Yoshida | |||
Koichi Matsuzaki | |||
Yutaka Inagaki | |||
Mikio Nishizawa | |||
Toshihito Seki | |||
Yoshiya Tahashi | |||
Hideo Yamagata | |||
Masanori Matsushita | |||
Fukiko Furukawa | |||
Junichi Fujisawa | |||
Kyoichi Inoue | |||
P2860 | cites work | The New England Journal of Medicine | Q582728 |
Journal of Cellular Physiology | Q1524270 | ||
Genes & Development | Q1524533 | ||
Journal of Clinical Investigation | Q3186904 | ||
Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene | Q24596458 | ||
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells | Q27860599 | ||
TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling | Q28243202 | ||
Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling | Q28251743 | ||
Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction | Q28271470 | ||
Smads: transcriptional activators of TGF-beta responses | Q28292325 | ||
Mitogen-activated protein kinase pathways | Q29618431 | ||
Regulation of Smad activity | Q33830190 | ||
Role of Ras and Mapks in TGFbeta signaling | Q33857574 | ||
The Smads: transcriptional regulation and mouse models | Q33857580 | ||
Hepatic stellate cells as a target for the treatment of liver fibrosis | Q34391409 | ||
Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells | Q34580695 | ||
A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras | Q35193411 | ||
Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases | Q35201617 | ||
Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury | Q40757687 | ||
Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture. | Q40891185 | ||
Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential | Q40921225 | ||
Molecular mechanisms of liver fibrogenesis--a homage to the role of activated fat-storing cells | Q40940134 | ||
Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury | Q41893786 | ||
Synergistic regulation of inducible nitric oxide synthase gene by CCAAT/enhancer-binding protein beta and nuclear factor-kappaB in hepatocytes | Q42458991 | ||
Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic | Q74292004 | ||
Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration | Q77726417 | ||
Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression | Q78239880 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phosphorylation | Q242736 |
P304 | page(s) | 879-889 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts | |
P478 | volume | 38 |
Q36743890 | A Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer Biology |
Q26745650 | Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview |
Q24650762 | Biology of fibroblasts and myofibroblasts |
Q42481241 | CCL18-stimulated upregulation of collagen production in lung fibroblasts requires Sp1 signaling and basal Smad3 activity |
Q55494181 | Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis. |
Q58574755 | Crosstalk between mitogen-activated protein kinase inhibitors and transforming growth factor-β signaling results in variable activation of human dermal fibroblasts |
Q89786371 | Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation |
Q31060222 | Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer |
Q38790780 | Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer |
Q37998023 | Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries |
Q57471749 | Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism |
Q31158693 | Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo |
Q92759402 | Effects of epidermal growth factor on transforming growth factor-beta1-induced epithelial-mesenchymal transition and potential mechanism in human corneal epithelial cells |
Q36736835 | Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. |
Q36941185 | Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy |
Q33916545 | Enhanced transforming growth factor-beta signaling and fibrogenesis in ovine fetal skeletal muscle of obese dams at late gestation |
Q34575283 | Essential role of Smad3 in angiotensin II-induced vascular fibrosis |
Q50128937 | FGF2-mediated attenuation of myofibroblast activation is modulated by distinct MAPK signaling pathways in human dermal fibroblasts |
Q39630057 | Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease. |
Q37310859 | Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity |
Q51737629 | Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice. |
Q28582127 | Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation |
Q34451277 | Inhibition of acidic sphingomyelinase reduces established hepatic fibrosis in mice |
Q39321024 | Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts. |
Q40415540 | Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells |
Q93090410 | Integration of high‑throughput data of microRNA and mRNA expression profiles reveals novel insights into the mechanism of liver fibrosis |
Q47097555 | Interaction of microRNA-21/145 and Smad3 domain-specific phosphorylation in hepatocellular carcinoma. |
Q54567736 | JinSanE decoction, a chinese herbal medicine, inhibits expression of TGF-beta1/Smads in experimental hepatic fibrosis in rats. |
Q38266863 | Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma |
Q41890914 | Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling |
Q54298655 | MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells. |
Q39007563 | MAPK inhibitors modulate Smad2/3/4 complex cyto-nuclear translocation in myofibroblasts via Imp7/8 mediation. |
Q42099833 | Major HGF-mediated regenerative pathways are similarly affected in human and canine cirrhosis |
Q34163687 | Maternal obesity enhances collagen accumulation and cross-linking in skeletal muscle of ovine offspring |
Q34425988 | Maternal obesity induces fibrosis in fetal myocardium of sheep |
Q28084572 | Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? |
Q26769611 | Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? |
Q37527808 | Microarray expression profiles of genes in lung tissues of rats subjected to focal cerebral ischemia-induced lung injury following bone marrow-derived mesenchymal stem cell transplantation |
Q52351133 | Mitogen-activated protein kinase inhibitors reduce the nuclear accumulation of phosphorylated Smads by inhibiting Imp 7 or Imp 8 in HepG2 cells. |
Q40362636 | Modulation of angiotensin II signaling in the prevention of fibrosis |
Q90482425 | Myocardial Cell Signaling During the Transition to Heart Failure: Cellular Signaling and Therapeutic Approaches |
Q46509125 | NAD(P)H oxidase plays a crucial role in PDGF-induced proliferation of hepatic stellate cells |
Q37888661 | New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis |
Q40289722 | Nicotine inhibits myofibroblast differentiation in human gingival fibroblasts |
Q36940906 | Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis |
Q47102830 | PDGFR Signaling Mediates Hyperproliferation and Fibrotic Responses of Subsynovial Connective Tissue Cells in Idiopathic Carpal Tunnel Syndrome. |
Q40225700 | PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells |
Q36116217 | Phospho-specific Smad3 signaling: impact on breast oncogenesis |
Q35237708 | Phosphorylation of Smad2/3 at specific linker threonine indicates slow-cycling intestinal stem-like cells before reentry to cell cycle |
Q35234341 | Phosphorylation of Smad2/3 at the specific linker threonine residue indicates slow-cycling esophageal stem-like cells before re-entry to the cell cycle. |
Q33581891 | Pin1 promotes transforming growth factor-beta-induced migration and invasion |
Q53554147 | Receptor channel TRPC6 orchestrate the activation of human hepatic stellate cell under hypoxia condition. |
Q35427394 | Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver |
Q26771696 | Reversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal Transitions |
Q42246559 | Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection |
Q37644559 | Role of host genetics in fibrosis. |
Q36921552 | Roles of Smad3 in TGF-beta signaling during carcinogenesis |
Q30594252 | Roles of transforming growth factor-β1 and OB-cadherin in porcine cardiac valve myofibroblast differentiation. |
Q35532091 | SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma |
Q37509215 | Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-β in a cell phenotype-specific manner |
Q93001489 | Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis |
Q35478946 | Smad phosphoisoform signaling specificity: the right place at the right time |
Q35649316 | Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells |
Q35779047 | Smad3 as a mediator of the fibrotic response |
Q50588263 | Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. |
Q26863522 | Smad3 phospho-isoform signaling in hepatitis C virus-related chronic liver diseases |
Q39708889 | Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts |
Q40522842 | TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions |
Q37946756 | TGF-β in progression of liver disease |
Q38165027 | TGF-β signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases |
Q37899212 | TGF-β signaling in fibrosis |
Q44537770 | TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. |
Q34120419 | TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). |
Q36337915 | TGFbeta pathobiology in the eye. |
Q64941777 | The Effects of Retinoic Acid and MAPK Inhibitors on Phosphorylation of Smad2/3 Induced by Transforming Growth Factor β1. |
Q50575299 | The Smad3/Smad4/CDK9 complex promotes renal fibrosis in mice with unilateral ureteral obstruction. |
Q39121230 | The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma |
Q33791954 | The specific linker phosphorylation of Smad2/3 indicates epithelial stem cells in stomach; particularly increasing in mucosae of Helicobacter-associated gastritis. |
Q36371664 | Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis |
Q64263531 | Transcriptional regulation of Hepatic Stellate Cell activation in NASH |
Q58754397 | Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis |
Q38585912 | Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury |
Q36495212 | Transforming growth factor-beta during carcinogenesis: the shift from epithelial to mesenchymal signaling |
Q39883712 | Transforming growth factor-{beta}-inducible phosphorylation of Smad3 |
Q34789300 | Transforming growth factor-β and the hallmarks of cancer |
Q38973928 | Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling |
Q57478274 | Wnt/β-Catenin Signaling as a Potential Target for the Treatment of Liver Cirrhosis Using Antifibrotic Drugs |
Q36520310 | c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma |
Q51142381 | p38 Mitogen-activated protein kinase affects transforming growth factor-beta/Smad signaling in human dental pulp cells. |
Q34099998 | p38 mitogen-activated protein kinase is critical for synergistic induction of the FSH(beta) gene by gonadotropin-releasing hormone and activin through augmentation of c-Fos induction and Smad phosphorylation |
Search more.